← All stocks

Xeris Biopharma Holdings, Inc.

XERS Net selling
CIK 0001867096 #2214 in the set updated 17 Sep 2026
Bought (120 mo)
$1.21M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.55M
$3.43M on a plan · $711.33K straight out of an exercise
Sold at will
$2.41M
5 of 35 sales
Net
−$5.34M
−$1.21M against sales at will

By person

18 insiders · 61 transactions
33.1×

John Shannon holds 33.1 times base salary in stock. $24.64M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $8.50, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
JOHNSON JOHN
Director
$1.85M (3)
−$1.85M
707,276
0.3879%
$6.01M
Hecht Beth
See Remarks
$1.52M (13) scheduled
−$1.52M
1,127,796
0.6186%
$9.59M
+2,919%
McCulloch Kevin
See Remarks
$109.48K (1)
$1.09M (4) scheduled
−$980.58K
1,664,208
0.9128%
$14.15M
+11.6%
Edick Paul R
See Remarks
$654.60K (5)
+$654.60K
3,821,494
2.10%
$32.48M
HALKUFF DAWN
Director
$9.95K (1)
$431.11K (2)
−$421.16K
124,603
0.0683%
$1.06M
Pieper Steven
See Remarks
$104.52K (2)
$468.18K (4) scheduled
−$363.66K
1,356,053
0.7438%
$11.53M
+7,469%
SHERMAN JEFFREY W
Director
$10.10K (1)
$334.52K (1) scheduled
−$324.42K
224,588
0.1232%
$1.91M
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director
$203.92K (2) scheduled
−$203.92K
150,693
0.0827%
$1.28M
PERSKY MARLA
Director
$10.06K (1)
$211.04K (2) scheduled
−$200.99K
157,063
0.0861%
$1.34M
Shannon John Patrick Jr
See Remarks
$259.90K (3)
$349.66K (2) scheduled
−$89.76K
2,898,933
1.59%
$24.64M
+8,892%
Brady James Aloysius
Director
$60.04K (1) scheduled
−$60.04K
113,359
0.0622%
$963.55K
Schmid John P.
Director
$50.13K (5)
+$50.13K
138,359
0.0759%
$1.18M
PRESTRELSKI STEVEN
Chief Scientific Officer
$27.16K (1) scheduled
−$27.16K
719,780
0.3948%
$6.12M
Nguyen Anh Tu
See Remarks
395,023
0.2167%
$3.36M
+30.4%
JOHNSON KENNETH ERLAND
See Remarks
320,446
0.1758%
$2.72M
+3,278%
Kong Garheng
Director
238,337
0.1307%
$2.03M
Fairley Ricki Louise
Director
135,000
0.0740%
$1.15M
KREHER NERISSA
Director
33,582
0.0184%
$285.45K
Insider
Date
Role
Action
Shares
Price
Amount
McCulloch Kevin
12 Mar 2026
See Remarks
Exercised, kept
4
$3.94
$15.76
McCulloch Kevin
12 Mar 2026
See Remarks
Exercised, kept
48,894
$4.09
$199.98K
Pieper Steven
5 Mar 2026
See Remarks
Exercised, kept
14,036
$5.93
$83.23K
Pieper Steven
5 Mar 2026
See Remarks
Exercised, kept
27,891
$4.09
$114.07K
Shannon John Patrick Jr
14 Nov 2025
See Remarks
Exercised, kept
87,100
$1.55
$135.01K
Pieper Steven
22 Nov 2024
See Remarks
Exercised, kept
19,483
$1.55
$30.20K
JOHNSON JOHN
18 Mar 2024
Director
Exercised, kept
215,600
$1.99
$429.04K

What was left out

Form 4 filings counted 148
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 17,775,953
History held since 5 Oct 2021